Cargando…
Respuesta a “Taquicardia, efecto adverso, vacuna COVID-19”
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234780/ https://www.ncbi.nlm.nih.gov/pubmed/35783350 http://dx.doi.org/10.1016/j.eimc.2022.05.017 |
| _version_ | 1784736155398307840 |
|---|---|
| author | García, Ma Teresa Marco Lana, Álvaro Torres Agudo, Ma Berta Anta Delgado, Ma de la Trinidad Rufino |
| author_facet | García, Ma Teresa Marco Lana, Álvaro Torres Agudo, Ma Berta Anta Delgado, Ma de la Trinidad Rufino |
| author_sort | García, Ma Teresa Marco |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9234780 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92347802022-06-27 Respuesta a “Taquicardia, efecto adverso, vacuna COVID-19” García, Ma Teresa Marco Lana, Álvaro Torres Agudo, Ma Berta Anta Delgado, Ma de la Trinidad Rufino Enferm Infecc Microbiol Clin Carta al Editor Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. 2023-01 2022-06-13 /pmc/articles/PMC9234780/ /pubmed/35783350 http://dx.doi.org/10.1016/j.eimc.2022.05.017 Text en © 2022 Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Carta al Editor García, Ma Teresa Marco Lana, Álvaro Torres Agudo, Ma Berta Anta Delgado, Ma de la Trinidad Rufino Respuesta a “Taquicardia, efecto adverso, vacuna COVID-19” |
| title | Respuesta a “Taquicardia, efecto adverso, vacuna COVID-19” |
| title_full | Respuesta a “Taquicardia, efecto adverso, vacuna COVID-19” |
| title_fullStr | Respuesta a “Taquicardia, efecto adverso, vacuna COVID-19” |
| title_full_unstemmed | Respuesta a “Taquicardia, efecto adverso, vacuna COVID-19” |
| title_short | Respuesta a “Taquicardia, efecto adverso, vacuna COVID-19” |
| title_sort | respuesta a “taquicardia, efecto adverso, vacuna covid-19” |
| topic | Carta al Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234780/ https://www.ncbi.nlm.nih.gov/pubmed/35783350 http://dx.doi.org/10.1016/j.eimc.2022.05.017 |
| work_keys_str_mv | AT garciamateresamarco respuestaataquicardiaefectoadversovacunacovid19 AT lanaalvarotorres respuestaataquicardiaefectoadversovacunacovid19 AT agudomabertaanta respuestaataquicardiaefectoadversovacunacovid19 AT delgadomadelatrinidadrufino respuestaataquicardiaefectoadversovacunacovid19 |